USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	062376/0850			Pages:	8
		Recorded:	01/13/2023
Attorney Dkt #:	309646-206
Conveyance:	RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS).

Total properties: 27

Patent #:	7709227	Issue Dt:	05/04/2010	Application #:	11620034	Filing Dt:	01/04/2007
Publication #:	US20080032400	Pub Dt:	02/07/2008
Title:	MULTIMERIC ELP FUSION CONSTRUCTS

Patent #:	9029505	Issue Dt:	05/12/2015	Application #:	12857103	Filing Dt:	08/16/2010
Publication #:	US20110178017	Pub Dt:	07/21/2011
Title:	MODIFIED VASOACTIVE INTESTINAL PEPTIDES

Patent #:	NONE	Issue Dt:		Application #:	14099590	Filing Dt:	12/06/2013
Publication #:	US20140171370	Pub Dt:	06/19/2014
Title:	FORMULATIONS OF ACTIVE AGENTS FOR SUSTAINED RELEASE

Patent #:	9561262	Issue Dt:	02/07/2017	Application #:	14124612	Filing Dt:	11/04/2014
Publication #:	US20150111829	Pub Dt:	04/23/2015
Title:	USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION

Patent #:	9700598	Issue Dt:	07/11/2017	Application #:	14681597	Filing Dt:	04/08/2015
Publication #:	US20160220642	Pub Dt:	08/04/2016
Title:	MODIFIED VASOACTIVE INTESTINAL PEPTIDES

Patent #:	10940182	Issue Dt:	03/09/2021	Application #:	15276151	Filing Dt:	09/26/2016
Publication #:	US20170072021	Pub Dt:	03/16/2017
Title:	USE OF MODIFIED VASOACTIVE INTESTINAL PEPTIDES IN THE TREATMENT OF HYPERTENSION

Patent #:	11052132	Issue Dt:	07/06/2021	Application #:	15308626	Filing Dt:	11/03/2016
Publication #:	US20170182130	Pub Dt:	06/29/2017
Title:	METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS

Patent #:	9919032	Issue Dt:	03/20/2018	Application #:	15355386	Filing Dt:	11/18/2016
Publication #:	US20170136092	Pub Dt:	05/18/2017
Title:	A METHOD FOR ADMINISTERING A SUSTAINED RELEASE FORMULATION

Patent #:	10722590	Issue Dt:	07/28/2020	Application #:	15527985	Filing Dt:	05/18/2017
Publication #:	US20190015523	Pub Dt:	01/17/2019
Title:	ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

Patent #:	10688156	Issue Dt:	06/23/2020	Application #:	15546037	Filing Dt:	07/25/2017
Publication #:	US20180333467	Pub Dt:	11/22/2018
Title:	METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS

Patent #:	NONE	Issue Dt:		Application #:	15621320	Filing Dt:	06/13/2017
Publication #:	US20180008677	Pub Dt:	01/11/2018
Title:	MODIFIED VASOACTIVE INTESTINAL PEPTIDES

Patent #:	10085984	Issue Dt:	10/02/2018	Application #:	15857950	Filing Dt:	12/29/2017
Publication #:	US20180185362	Pub Dt:	07/05/2018
Title:	METALLOENZYME INHIBITOR COMPOUNDS

Patent #:	10538511	Issue Dt:	01/21/2020	Application #:	15858015	Filing Dt:	12/29/2017
Publication #:	US20180186773	Pub Dt:	07/05/2018
Title:	METALLOENZYME INHIBITOR COMPOUNDS

Patent #:	NONE	Issue Dt:		Application #:	16099261	Filing Dt:	11/06/2018
Publication #:	US20190218274	Pub Dt:	07/18/2019
Title:	ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

Patent #:	11040034	Issue Dt:	06/22/2021	Application #:	16124846	Filing Dt:	09/07/2018
Publication #:	US20190008861	Pub Dt:	01/10/2019
Title:	METALLOENZYME INHIBITOR COMPOUNDS

Patent #:	11103558	Issue Dt:	08/31/2021	Application #:	16720970	Filing Dt:	12/19/2019
Publication #:	US20200282022	Pub Dt:	09/10/2020
Title:	THERAPEUTIC AGENTS COMPRISING A BMP-9 PEPTIDE AND ELEASTIN-LIKE PEPTIDES

Patent #:	11136309	Issue Dt:	10/05/2021	Application #:	16746098	Filing Dt:	01/17/2020
Publication #:	US20200392112	Pub Dt:	12/17/2020
Title:	METALLOENZYME INHIBITOR COMPOUNDS

Patent #:	11266719	Issue Dt:	03/08/2022	Application #:	16907759	Filing Dt:	06/22/2020
Publication #:	US20210069299	Pub Dt:	03/11/2021
Title:	METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS

Patent #:	NONE	Issue Dt:		Application #:	16939624	Filing Dt:	07/27/2020
Publication #:	US20200353091	Pub Dt:	11/12/2020
Title:	ELP FUSION PROTEINS FOR CONTROLLED AND SUSTAINED RELEASE

Patent #:	NONE	Issue Dt:		Application #:	17278075	Filing Dt:	03/19/2021
Publication #:	US20210347915	Pub Dt:	11/11/2021
Title:	METHODS OF REVERSING TICAGRELOR ACTIVITY

Patent #:	NONE	Issue Dt:		Application #:	17350726	Filing Dt:	06/17/2021
Publication #:	US20210322409	Pub Dt:	10/21/2021
Title:	METALLOENZYME INHIBITOR COMPOUNDS

Patent #:	NONE	Issue Dt:		Application #:	17365443	Filing Dt:	07/01/2021
Publication #:	US20220023390	Pub Dt:	01/27/2022
Title:	METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS

Patent #:	NONE	Issue Dt:		Application #:	17421567	Filing Dt:	07/08/2021
Publication #:	US20220081420	Pub Dt:	03/17/2022
Title:	METALLOENZYME INHIBITOR COMPOUNDS

Patent #:	11919883	Issue Dt:	03/05/2024	Application #:	17462909	Filing Dt:	08/31/2021
Publication #:	US20220009907	Pub Dt:	01/13/2022
Title:	METALLOENZYME INHIBITOR COMPOUNDS

Patent #:	NONE	Issue Dt:		Application #:	17583883	Filing Dt:	01/25/2022
Publication #:	US20220288170	Pub Dt:	09/15/2022
Title:	METHODS AND COMPOSITIONS FOR TREATING MUSCLE DISEASE AND DISORDERS

Patent #:	NONE	Issue Dt:		Application #:	17633369	Filing Dt:	02/07/2022
Publication #:	US20220289812	Pub Dt:	09/15/2022
Title:	ELP FUSION PROTEINS COMPRISING PARATHYROID HORMONE FOR CONTROLLED AND SUSTAINED RELEASE

Patent #:	NONE	Issue Dt:		Application #:	17739491	Filing Dt:	05/09/2022
Publication #:	US20230192895	Pub Dt:	06/22/2023
Title:	PHARMACOKINETIC & PHARMACODYNAMIC MODEL FOR DETERMINING EFFECTIVE DOSE OF ANTI-TICAGRELOR ANTIBODY

Assignor

Exec Dt:

01/13/2023

Assignee

1 GREAT VALLEY PARKWAY, SUITE 30

MALVERN, PENNSYLVANIA 19355

Correspondence name and address
	JENNIFER GU C/O COOLEY LLP
	3175 HANOVER STREET
	PALO ALTO, CA 94304

Search Results as of: 05/30/2024 01:48 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6